Updated: Wed, 10/02/2024 - 13:45

From Saturday, Oct. 5 through Monday, Oct. 7, the Downtown and Macdonald Campuses will be open only to McGill students, employees and essential visitors. Many classes will be held online. Remote work required where possible. See Campus Public Safety website for details.

Du samedi 5 octobre au lundi 7 octobre, le campus du centre-ville et le campus Macdonald ne seront accessibles qu’aux étudiants et aux membres du personnel de l’Université McGill, ainsi qu’aux visiteurs essentiels. De nombreux cours auront lieu en ligne. Le personnel devra travailler à distance, si possible. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

Home / People

Sylvie Mader

Academic title(s): 

Full Member, McGill Centre for Translational Research in Cancer
Principal Investigator, Molecular Targeting in Breast Cancer research unit, IRIC Professor, Department of Biochemistry, Faculty of Medicine, Université de Montréal Adjunct Professor, Department of Medicine, Experimental Medicine Program, McGill University Holder of the CIBC research chair on the causes of breast cancer

Sylvie Mader
Contact Information
Address: 

Département de biochimie
Faculté de Médecine
Pavillon Roger-Gaudry - B-336-1
Université de Montréal
C.P. 6128, Succ. Centre-ville
Montreal, Quebec H3C 3J7

Phone: 
514-343-7166
Email address: 
sylvie.mader [at] umontreal.ca
Group: 
Molecular modeling and new drug development: Development of Biological and Chemical Agents
Link(s): 
Dr. Mader's profile at IRIC
Current research: 

Dr. Mader's research team uses large-scale genomics, proteomics and bioinformatics to characterize signaling pathways contributing to breast tumorigenesis in cell culture and in vivo tumorigenesis models. The team uses molecular modeling combined with structural studies to design novel molecules targeting key proteins. The activity profile of new molecules synthesized by medicinal chemistry as a result of these studies is tested in the experimental models used in the laboratory, which include purification of breast cancer stem cells

Back to top